Clinical note: don039t-buy-medical-products-on-unit-price-alone-lessons-from-molnlycke-ecg-149

Here's the conclusion I'd give any new procurement person in health care: the number that matters most is rarely on the quote. Unit price is easy to compare, but it misses what a product actually costs once it enters a hospital supply chain. A dressing with a slightly higher per-sheet price may reduce painful dressing changes. An ECG machine with a lower quote may require expensive EMR integration and proprietary consumables. A robotic surgery system with an attractive acquisition price may become a budget problem if procedure volume doesn't justify the service contract. The real price is the total cost of making that product work in your specific environment.

I'm a procurement manager at a 220-bed regional health system. For the past six years, I've managed an annual clinical supplies budget of roughly $1.8 million and negotiated with more than 40 vendors. I don't have hard data on industry-wide purchasing failures; what I have is our own purchase order history, and it tells a pretty clear story. Most of our post-purchase cost surprises came from specification mismatches, not from being quoted a few dollars too high. That's why I now think about procurement as prevention, not just purchasing.

Most buyers focus on the 'what's your best price?' question and completely miss the costs that show up after implementation: training, integration, consumables, downtime, maintenance, and disposal. The question everyone should ask is not only 'what does it cost?' but 'what has to happen after we buy it before it can be used safely and effectively?'

The TCO checklist I use before every significant purchase

After the third contract headache in one year, I built a total cost of ownership template. It isn't complicated, but it forces each requester to think beyond the product demo.

1. What consumables or compatible accessories are required?
2. What training and implementation support are not included in the quote?
3. How does it connect to our EMR, lab system, or existing device fleet?
4. What does the service contract look like after the warranty period?
5. What evidence supports the clinical or operational claim?
6. How many procedures, tests, or uses are needed per month to justify the cost?

The last question is the one I used to skip. It's also the one that has saved us the most money.

Wound care: why we use Molnlycke Mepiform with Safetac technology

A good example is wound care and scar management. One of our formulary items is the Molnlycke Mepiform dressing with Safetac technology. In our supplier database, Molnlycke Health Care US is the vendor record, and we buy Mepiform for patients who need a gentle silicone dressing that can be removed without causing more skin trauma. The dressing costs more per sheet than a roll of generic silicone tape. On a simple cost-per-item spreadsheet, the generic choice looks better. But the spreadsheet doesn't know anything about fragile skin, dressing change frequency, or patient comfort.

That doesn't mean we buy the premium product automatically. When the clinical team first recommended it, I asked for the evidence behind the safety and performance claims. Per FTC guidelines (ftc.gov), claims in advertising have to be truthful, non-misleading, and substantiated. That's a useful procurement lever, not just a legal rule. I wanted to see the clinical documentation before we added it to the formulary. Once we did add it, we also set up a short training session for the wound care nurses. The product made sense for our patient mix, but only because we checked the workflow around it.

The most frustrating part of that kind of purchase is watching a good product fail because nobody planned for application training or patient selection. You'd think a purchase request would include those details, but it rarely does.

ECG machine procurement: the hidden costs are in the system, not the device

We went through the same exercise when we replaced ECG machines. Our initial quotes ranged from about $4,800 to $9,200 for a 12-lead ECG machine. The cheaper quote looked good until we mapped the full system: EMR interface, staff training, calibration schedule, and the electrodes the machine uses. One quote looked like the best deal but required an additional interface module for our cardiology system. After adding that cost across four machines, the cheaper option was actually more expensive over a five-year period.

An ECG machine is not a standalone box. It has to send data to a chart, print reports, and be used by people who didn't grow up with that particular interface. A lot of buyers compare only hardware prices and then wonder why implementation costs more than the device. That is an outsider blind spot, and it's expensive. In our case, the higher quote included training, integration, and a service plan. The lower quote didn't. The lower quote wasn't a bad deal; it was just incomplete.

Robotic surgery systems: volume is the real financial driver

Now let me get into a tougher category: a robotic surgery system. Unlike a dressing or an ECG machine, a robotic surgery system is closer to a platform decision. Vendors may offer attractive upfront pricing because the long-term revenue comes from instruments, service, and training. If a hospital buys the system but doesn't run enough procedures to maintain surgeon skills, the per-case cost becomes enormous.

I learned this from watching an expensive surgical platform sit underused at a system I worked with earlier in my career. It wasn't a robotic surgery system, but the financial pattern was identical. The capital request was approved based on projected case volume, and nobody verified whether the schedule, surgeon interest, and trained OR team could actually support that number. The fixed costs didn't disappear. They just got spread across fewer cases. That experience changed how I review capital requests. Now I ask for a monthly procedure projection and the assumptions behind it before I evaluate the vendor's pricing structure.

A robotic surgery system can be a great investment for the right hospital. But the right hospital is not the one with the biggest capital budget. It's the one where utilization will be high enough to keep the program sustainable.

What is gel electrophoresis? A procurement translation

Lab equipment is another common blind spot. If someone in procurement searches 'what is gel electrophoresis?', it's usually because they need to buy some version of it and want to understand what they're approving. In simple terms, gel electrophoresis is a lab method that separates DNA, RNA, or proteins by size using an electric field and a gel medium. That basic definition is useful, but the purchase decision depends on the workflow around the method.

When our research group requested a gel electrophoresis system, the quote looked straightforward: instrument price, shipping, and installation. Then we asked about the full workflow. What running buffer does it need? What type of gel? How will the results be imaged and analyzed? Does the lab already have that software, or is it an additional sellable module? None of those costs were obvious from the brochure. I don't think the vendor was hiding anything. The request was written around a product name instead of a workflow, so the quote reflected the product, not the system.

That's a mistake I still see all the time in procurement, especially with capital equipment and lab devices. People feel pressure to move fast, and checking every integration point feels like delay. But five minutes of verification before a PO beats five hours of correction after it.

Where this approach has limits

I don't want to oversell the checklist. There are purchases where a heavy total cost analysis is overkill. A reminder pen, a box of standard gauze, or a $30 spare part doesn't need the same review as a robotic surgery system. If you apply the same process to every small order, you'll waste exactly the time you're trying to save.

There's also a clinical limit. Cost control should never override a justified patient need. Sometimes the clinically appropriate product is more expensive, and procurement's job is to reduce waste around that decision, not block it. My goal isn't to buy the cheapest thing. My goal is to make sure the hospital doesn't pay twice for the same product: once at purchase and again for the problems that could have been prevented.

So if there's one habit worth taking from this, it's this: read the quote, look at the clinical workflow, and ask what will happen on day two after the product arrives. That's where the real cost of medical procurement lives.